Contact and place of performance
Jessica Kiser
San Juan, PR 00921-3201
USA
The Orlando Veterans Affairs Healthcare System intends to solicit and award an acquisition for ThyroSeq: Thyroid Cancer Test. The performance period for this contract will date of award to date of completion. The Primary North American Industry Classification System (NAICS) for this acquisition is 621511, with a related small business size standard of $35 Million. The proposed action is for Firm-Fixed Price (FFP) req...
View moreThe Orlando Veterans Affairs Healthcare System has issued a presolicitation notice for the acquisition of ThyroSeq Thyroid Cancer Tests under solicitation number 36C24821Q0213. This requirement is classified under NAICS 621511 Medical Laboratories and PSC 6640 LABORATORY EQUIPMENT AND SUPPLIES. The agency intends to award a firm-fixed-price requirement contract designated as Unrestricted-other than small business. The performance period begins on the date of award and continues through the date of completion, with the primary place of performance located in San Juan, Puerto Rico.
Prospective offerors must be registered in the System for Award Management to be eligible for award. The solicitation incorporates provisions and clauses effective through Federal Acquisition Circular 2021-02. Documentation for this notice includes one attachment, 36C24821Q0213_1.docx, which was published on December 11, 2020. All questions regarding this procurement are due by December 16, 2020, and final responses must be submitted via email to Contract Specialist Jessica Kiser by December 18, 2020, at 12:00 PM Eastern Standard Time.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.